Regeneron Pharmaceuticals Inc Regn Q3 2018 Earnings Conference Call Transcript | Latest News RSS feed

Regeneron Pharmaceuticals Inc Regn Q3 2018 Earnings Conference Call Transcript - Latest News


Regeneron Pharmaceuticals (REGN) Q3 2018 Results - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2018 Earnings Call November 6 ... Kasimov - JPMorgan Securities LLC Welcome to the Regeneron Pharmaceuticals Q3 2018 Earnings Conference Call. My name ... read more

Regeneron, Sanofi Select Two Clinical-stage Antibodies For Ongoing Collaboration

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced the company and Sanofi have restructured ... of the immuno-oncology discovery program costs for the last quarter of 2018 and up to $120 mil... read more

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen Inc. (NASDAQ: AMGN) on a cholesterol drug patent. However, Regeneron and ... read more

Looking for another news?


Is a Beat in the Cards for Allergan (AGN) in Q3 Earnings?

Factors to Consider On the second-quarter conference call ... company has an Earnings ESP of +0.56% and is a Zacks #2 Ranked stock. You can see the complete list of today’s Zacks #1 Rank stocks here. ... read more


Regeneron Pharmaceuticals Inc Gross Profit (Semi Annual)

This details the amount of earnings left that a firm is able to use for other purposes. Increasing gross profits are a good sign for a company (it means the company is generating money from sales). It ... read more

Will AbbVie Outsmart Biosimilars, and Can Clovis Win the PARP Race?

A full transcript follows ... the FDA early or midyear of 2018. But it's definitely one to watch, because it's going to have big implications on this indication. Harjes: Another interesting part of th... read more

Regeneron Pharmaceuticals (REGN) STOCK REGN STOCK

Regeneron Pharmaceuticals, Inc. engages in the discovery, invention, development, manufacture, and commercialization of medicines for the treatment of serious diseases. It products include the followi... read more

Top Analyst Upgrades and Downgrades: Angie’s List, Itron, NVIDIA, Regeneron, Sempra, More

Earnings season is winding down and the markets are ... Canaccord Genuity maintained its Hold rating based on limited growth prospects. Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was downgraded to ... read more

Regeneron Pharmaceuticals Inc Average Basic Shares Outstanding (Quarterly)

Average Basic Shares Outstanding are the average number of current shares in company's stock outstanding over the reporting period, before accounting for the effects of dilution from events like exerc... read more

Spectrum (SPPI) Initiates Phase II Study for Cancer Drug

Some other top-ranked stocks in health care sector include Alexion Pharmaceuticals, Inc. ALXN, Regeneron Pharmaceuticals, Inc. REGN ... earnings per share estimates have moved up from $4.55 to $4.77 f... read more

Regeneron Pharmaceuticals (REGN) Q2 2018 Results - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2018 Earnings Call August 2 ... Raymond - Piper Jaffray & Co. Welcome to the Regeneron Pharmaceuticals Second Quarter 2018 Earnings Conference Call. My ... read more

Regeneron Pharmaceuticals Inc (REGN) Q3 2018 Earnings Conference Call Transcript

Image source: The Motley Fool. Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2018 Earnings Conference Call Nov. 06, 2018, 8:30 a.m. ET Operator Welcome to the Regeneron Pharmaceuticals Q3 2018 Earni... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us